Last reviewed · How we verify
A solution of 0.2% SLS
At a glance
| Generic name | A solution of 0.2% SLS |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- A solution of 0.2% SLS CI brief — competitive landscape report
- A solution of 0.2% SLS updates RSS · CI watch RSS
- Bayer portfolio CI